Bispecific antibody targets and therapies in multiple myeloma. [PDF]
Rees M+3 more
europepmc +1 more source
Novel bispecific antibody causes tumor regression in patients with non-Hodgkin lymphoma [PDF]
openalex +1 more source
European Principles of Nursing Care for Persons With Inherited Bleeding Disorders
ABSTRACT Introduction A nurse is one of the core members of the multidisciplinary haemophilia team. However, what people with inherited bleeding disorders (PwBD) can expect from them has not yet been formally defined. Aim This project, initiated by the EAHAD Nurses Committee, aimed to establish Principles of Nursing Care (PoNC) for PwBD to promote high‐
Nanda Uitslager+3 more
wiley +1 more source
Development of a T cell engaging bispecific antibody targeting long non-coding RNA PVT1. [PDF]
Kato H+12 more
europepmc +1 more source
Abstract T‐cell re‐directional therapies, including chimeric antigen receptor (CAR)‐T cell and bispecific antibodies (BsA), have transformed the treatment landscape to benefit patients with multiple myeloma. A number of these novel therapies has been approved internationally, with CAR‐T therapy recently approved in Australia.
P. Joy Ho, Eric W. Li
wiley +1 more source
Disparities in Clinical Trial Enrollment- Focus on CAR-T and Bispecific Antibody Therapies. [PDF]
Islam N, Budvytyte L, Khera N, Hilal T.
europepmc +1 more source
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma [PDF]
Edmund A. Rossi+4 more
openalex +1 more source
Research Advice for Early Career Transplant Infectious Disease Clinicians
ABSTRACT As part of an ongoing series of social media discussions, the Transplant Infectious Diseases Early Career Network hosted an open forum for the transplant infectious disease community to discuss the development of research careers for junior faculty. Topics discussed included opportunities for research, identifying potential research questions,
Rebecca N. Kumar+5 more
wiley +1 more source
Improving CD3 bispecific antibody therapy in solid tumors using combination strategies. [PDF]
Lloyd K+5 more
europepmc +1 more source
Recombinant Bispecific Monoclonal Antibodies Prepared by the Dock-and-Lock Strategy for Pretargeted Radioimmunotherapy [PDF]
Robert M. Sharkey+4 more
openalex +1 more source